Inomagen Therapeutics, Inc.
Biotechnology company · Chicago, Illinois, United States
Inomagen Therapeutics, Inc. is a biotechnology company headquartered in Chicago, Illinois, United States. Its earliest recorded incorporation is in 2014. It has received 2 US government small-business research awards (SBIR/STTR) from health agencies, $3.8 million in total, most recently in 2022. It has reported private securities offerings to the US SEC, most recently $140,000 sold in a notice filed in 2025.
Inomagen Therapeutics at a glance
What does Inomagen Therapeutics do?
US government research funding
2 SBIR/STTR small-business research awards from US health agencies, $3.8 million in total (2021 to 2022). NIH funding came from the National Heart, Lung, and Blood Institute.
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $140,000 sold (2025).
Frequently asked questions about Inomagen Therapeutics
Where is Inomagen Therapeutics headquartered?
Inomagen Therapeutics, Inc. is headquartered in Chicago, Illinois, United States.
What does Inomagen Therapeutics do?
Inomagen Therapeutics, Inc. is a biotechnology company.
When was Inomagen Therapeutics founded?
The earliest incorporation on record for Inomagen Therapeutics, Inc. is in 2014, according to public company registers.
Similar companies
- Metame Health Inc.Chicago, Illinois, United States
- Synapticure, Inc.Chicago, Illinois, United States
- BiomeSense, Inc.Chicago, Illinois, United States
- Nuago Therapeutics, Inc.Chicago, Illinois, United States
- Advanced Cooling Therapy, Inc.Chicago, Illinois, United States
- Diagnostic Photonics, Inc.Chicago, Illinois, United States
- Microsensor Labs, LLCChicago, Illinois, United States
- Zuchem IncChicago, Illinois, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences